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Background: Screening and determining the immune status of individuals for hepatitis B is usually done by
detecting hepatitis B surface antigen (HBsAg) and hepatitis B surface antigen-specific antibodies (HBsAb). In some
countries with the highest viral burden, performing these assays is currently impractical. This paper explores the use
of filter paper as a blood specimen transport medium.
Methods: Samples, chosen from routine clinical laboratory pool, were applied and dried onto filter paper. Eluates,
from the paper samples, were analyzed as routine clinical specimens on ADVIA Centaur 5634W immunoassay
analyzers using the standard HBsAg and HBsAb kits. Dried blood samples were subjected to a range of
environmental conditions in order to assess stability.
Results: After drying and elution the assays showed linearity and precision comparable to clinical assays performed
on fresh serum. Elutions at various times during a 149 day incubation period showed very little variability in the
Index numbers. All analytes were temperature stable except for a decrease in the HBsAg signal at 42°C.
Conclusions: Filter paper is an acceptable storage and transport medium for serum to be used in the detection of
hepatitis B markers if atmospheric variability can be controlled. HBsAg, HBsAb and HBcAb are all stable for at least
five months under storage conditions below room temperature. Drying specimens, particularly serum, on filter
paper at remote locations, offers a reasonable solution to the problem of hepatitis surveillance in underdeveloped
regions, although some attempt at temperature control might be desirable.
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Hepatitis B virus is a human pathogen that infects the
liver and can cause both acute and chronic disease.
More than 350 million individuals live with chronic
hepatitis B worldwide [1,2]. These individuals are often
asymptomatic but approximately 25% of adults who are
chronically infected will die of cirrhosis or hepatocellular
carcinoma secondary to the infection [3]. The best ap-
proach to reduce the burden of hepatitis B is to prevent
infection, mainly through vaccination and infection con-
trol measures [4]. There are also treatment options with
some effectiveness that include interferon, anti-viral
drugs and in some cases liver transplants.* Correspondence: sawppr@rit.edu
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reproduction in any medium, provided the orScreening for disease and determining the immune
status of individuals is usually done by detecting hepa-
titis B surface antigen (HBsAg), hepatitis B surface anti-
gen-specific antibodies (HBsAb) and hepatitis B core
antibodies (HBc). The presence of anti-HBsAg IgG is a
marker for immunity and used to determine whether a
patient needs to be vaccinated [5,6]. The most com-
monly used tests are immunoassays performed on fairly
complex analyzers by trained technologists [5-7]. In
some countries with the highest viral burden, such as
those in sub-Saharan Africa, performing these assays is
currently impractical due to the local unavailability of
laboratory resources.
Blood serum and plasma specimens have in many
instances been successfully collected and dried onto
paper media for subsequent testing elsewhere [8-17].
This paper explores the use of filter paper as a medium
on which to apply and dry serum or plasma specimenstd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tories possessing the required technology for the testing
of hepatitis B markers.
Methods
Specimen collection and immobilization onto paper
Specimens were chosen from the routine clinical labora-
tory at the Rochester General Hospital for study, repre-
senting the different laboratory presentations seen in
patients, including immunization, current chronic or
acute disease, and resolved infection. The specimen col-
lection plan was submitted and found to be exempt from
formal review by the Internal Review Board (IRB) at the
Rochester General Hospital. The Institutional Review
Board deemed this study to be exempt under Federal reg-
ulations after all patient identifiers were stripped from the
samples by a third party not involved in the research be-
fore being tested. 50 μl aliquots of the specimens were
absorbed into fifteen centimeter diameter filter paper
(Reeve AngelW 230- Whatman Inc.) and allowed to dry by
hanging at ambient temperature for a day. This paper has
a high absorptive capacity (5.0 ml per filter) for serum
and plasma (data not shown). Dried paper was stored in-
dividually in plastic bags at room temperature (21°C). No
silica gel desiccants were used in the plastic bags.
Disc elution
Paper discs were obtained from the filter paper by using
a hand punch (M.C. Mieth Manufacturing Inc.). Each
paper disc measured 8.73 mm. The specimens were
eluted with deionized water and pH 7.2 phosphate buf-
fered saline (Beckman-CoulterW) in watch glasses, using
the same volume of sample that had been originally ap-
plied to the filter paper. Some discs required tamping to
insure complete elution. The discs were stacked in
threes in the watch glasses and placed into the cylinders
of three milliliter disposable syringes (BD 3ml syringe –
Luer-Lok™ Tip) using metal forceps. The stacks were
tapped to the bottom of the syringes using a blunt rod,
and seated flat. The discs were eluted under gravity into
16 × 100 mm tube (Vacutainer) with no additives. When
no liquid was visible above the filter discs, final elutions
were made using the syringe plungers. The punch, watch
glass, forceps and blunt rod were thoroughly rinsed and
dried between specimens.
Hepatitis B analysis and characterization
Eluates were analyzed as routine clinical specimens on
ADVIA Centaur 5634W immunoassay analyzers (Sie-
mens) for surface antigen (HBsAg), total core antibody
(HBcAb), and surface antibody (HBsAb) following the
manufacturer recommendations. The ADVIA Centaur
assays are magnetic particle chemiluminometric immu-
noassays that use biotinylated mouse monoclonalcapture antibodies and acridinium-ester labeled mouse
monoclonal antibodies and streptavidin coated magnetic
latex particles. The cutoff Index value for positivity is
≥1.00 including results between 1.00-1.95 Index value
which are considered weakly reactive [18].
To characterize the properties of the samples after de-
hydration and elution, we performed studies of linearity,
precision, and stability at different conditions. The linear-
ity studies were conducted using serum from two differ-
ent patients, one for antigen, and the second for the two
antibodies. The high HBsAg titer sample (26,000 relative
light units in the original assay) was serially diluted from
1:5 to 1:10,000. HBcoreTotal and HBsAB linearity studies
were performed on dilution from 1:2.5 to 1:10,000. The
precision studies were performed by making 136 punches
from a saturated 15.0 cm filter. These discs were mixed
in the same plastic bag in which the filter was stored. Five
groups of fifteen random discs were removed, and the
specimens were eluted and assayed.
The correlation of results was described using R-
squared analysis, linear regression and a simple degree
of concordance calculation. Coefficient of variation was
defined as the ratio of the standard deviation to the
mean.
Specimen source, stability and uniformity
The first stability experiments were carried out on paper
saturated with a pool containing all three markers made
from different individual specimens. Samples were kept
at room temperature and assayed at one-week intervals
for the first month then monthly for four months, for
the three hepatitis B markers.
To determine the stability of the three markers over
time at different temperatures, a single 15 cm filter satu-
rated with the pool was used to obtain seventy-two filter
paper discs. The discs were mixed in a plastic bag. Three
discs were placed into each of 24 glassine envelopes
(Westvāco – Envelope Division). The envelopes were
stored from one day to 28 days under following condi-
tions: ambient temperature (77.5°F), refrigerator
temperature (4°C), freezer (−18°C), deep freeze (−78°C),
and 42°C incubator. An additional set of three discs was
exposed to gamma radiation from a cesium-source blood
irradiator for seven minutes and 12 seconds. The effect
of humidity was studied by placing five 15.0 cm filter
papers into environmental chambers at each of the fol-
lowing humidity levels: 20%, 50% and 90%.
To determine whether significant differences in analyte
recovery occurred regionally across the filter, a 15.0cm
filter was divided into 8 sectors, and each sector was
subdivided into a central and a peripheral section. In-
cluding a specimen from the actual center of the filter, a
total of 17 regions were assayed from the same original
filter paper.
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serum specimens, we attempted to determine the suit-
ability of plasma and whole blood as well. Serum,
plasma, and ethylenediaminetetraacetic acid (EDTA)
whole blood specimens were obtained via venipuncture
from positive patients and negative volunteers. Both
plasma and serum specimens were analyzed for baseline
levels of the three analytes. Serum, plasma, and whole
blood were applied to individual filters and dried. The
papers were processed as described. Tandem samples




After drying and elution the assays showed linearity and
precision comparable to clinical assays performed on
fresh serum. HBsAg testing after elution had a dynamic
range of 0.10 to 1000 Relative Light Units (RLUs; Index)
with a correlation coefficient R2 equal to 0.9992 when
compared to the results obtained from the fresh speci-
mens. The results for HBcAb and HBsAb were linear
from 1:2.5 to 1:100 and well correlated with the previ-
ously determined results. The dilutions from 1:250 to
1:10,000 were also statistically well correlated (Figure 1).
The coefficient of variation of the assays was less than
10%. The HBsAg range was 17127–19494. The HBcAb
range (Index) was 105.51–114.14. The HBsAB range
(Index) was 47.24–54.19.
Specimen stability
Elutions at various times during the 149 days showed
very little variability in the Index numbers produced byFigure 1 HBsAg Linearity and Dynamic Range Testing Following Pape
correlation coefficient (r2) of 0.9992, over a dynamic range of 0.10 to 1000
specimens. The RLU-Index values are provided for comparison.the assays with all three analytes being stable at room
temperature and below (−70 to 25.3°C). However, after
exposure to high atmospheric temperature (42°C) for an
undetermined amount of time signal was lost and the
targets denatured to the point that they could not be
detected by the assay. Representative data for HBsAg is
detailed in Figure 2. The HBsAg range was 12151–
15820 RLUs. The HBcAb range was 105.68–140.90
(RLUs). The HBsAb range was 72.04–92.09 (RLUs). The
calculated coefficients of variation were less than 10%.
The HBsAb values were stable at all temperatures
studied. The HBcAb value was stable at all lower tem-
peratures, but decreased 25% at 7 days and 33% at 14
days at 42°C. The HBsAg concentration was stable at all
lower temperatures, but showed decreases of 55% at 7
days and 68% at 14 days at 42°C.Specimen source
The whole blood elution showed a significant increase in
HBsAb, while the HbsAg and HBcoreTotal results were
unaffected by the presence of hemolysis. There was no
significant difference in the data obtained from the three
humidity levels of filter paper for HBsAg, HBsAb and
HBCore Total. Identical negative results were obtained
from serum and plasma of patients with no hepatitis B
markers.
A mapping study (data not shown) showed little vari-
ation in HBsAg results across all sectors tested. The
range of variability went from 17% above and 13% below
the average signal value in all regions that is within ac-
ceptable performance parameters. This variability did
not affect the interpretation of results for HBsAg.r Elution. The measured versus calculated results exhibited a
RLUs (Index), when compared to the results obtained from the fresh
Figure 2 Temperature Stability of the HBsAg Assay. Comparison of signal strength from samples stored at −78°C, -18°C, 4°C, 25.3°C and 42°C
for up to 28 days. Samples stored at all tempreatures were stable except for the samples stored at 42°C which degraded over time.
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terpretation (positive, negative or equivocal) between ini-
tial patient clinical results (serum specimens) and
subsequent results obtained from eluted filter papers
(Figure 3 a,b). Many of the false negatives had original
serum values below 10 which is considered not immune.Discussion
Filter paper is an acceptable storage and transport
medium for serum to be used in the detection of hepa-
titis B markers if temperature can be controlled. HBsAg,Figure 3 Comparison of the (a) HBsAg (n= 63 samples) and (b)
HBsAb (n= 39 samples) interpretation (positive, negative or
equivocal) between initial patient clinical results (serum
specimens) and subsequent results obtained from eluted filter
papers. The eleven discrepant results in the HBsAb assay were
related to very low signal in the original samples.HBsAb and HBcAb are all stable for at least five months
under storage conditions at or below 250C. The test
characteristics of linearity and precision were unchanged
when compared to the assays performed on fresh serum.
Humidity had no effect on the measurements obtained.
At 42°C there was a significant decrease in the measured
HBsAg. While the decrease was marked, interpretation
of the Index value did not change and the result would
have still been reported as positive for HBsAg. There
was also a slightly increased coefficient of variation at
42°C although the difference would not affect the final
interpretation of the values. We did not find a single dis-
crepant result when compared on the basis of interpret-
ation (positive or negative for markers). Serum is the
preferred testing sample rather than whole blood since
there is some positive bias for surface antibody when
using whole blood. This interference may be caused by
hemoglobin on the filter paper. Plasma did not show any
background interference.
Clearly, DBS techniques have been investigated for dec-
ades as a means of extending the reach of clinical services
into remote regions. Our results build on recent prior
studies that, collectively suggest, whole blood may be col-
lected and stabilized on a variety of different filter papers
[14-16,19,20]. Our results also confirm that the HBsAg,
reconstituted from immobilized dried whole blood, was
most sensitive to changes in ambient temperature [20,21].
Our results, however, do provide a pathway to DBS col-
lection validation when coupled with the sensitive chemi-
luminescent immunoassay technique. In our study, all
three markers remained above the positive cutoff even
when stored at 42°C for 28 days. This period would be
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regions. To our knowledge, our study is the first to sug-
gest that all three markers for hepatitis B may be immobi-
lized and dried onto filter paper, transported at elevated
temperatures over an extended period of time without re-
frigeration, and reconstituted to provide a positive assay
using a sensitive immunochemical analysis.
Conclusions
Drying specimens, particularly serum, on filter paper at
remote locations, offers a reasonable solution to the
problem of hepatitis surveillance in underdeveloped
regions, although some attempt at temperature control
might be desirable. Analytes are stable, and the papers
can be shipped to centralized facilities that have
advanced testing capabilities. Our proof-of-concept
work, using an immunofluorescence methodology
remains to be validated in field trials. These field trials
are currently under way in Rwanda.
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